Provided by Tiger Trade Technology Pte. Ltd.

Illumina

272.73
-0.3100-0.11%
Volume:108.03K
Turnover:29.64M
Market Cap:41.18B
PE:50.78
High:275.77
Open:273.00
Low:272.24
Close:273.04
52wk High:280.17
52wk Low:88.00
Shares:151.00M
Float Shares:149.05M
Volume Ratio:2.71
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.37
EPS(LYR):5.45
ROE:32.34%
ROA:8.67%
PB:14.51
PE(LYR):50.04

Loading ...

RBC Raises Price Target on Illumina to $310 From $230, Keeps Outperform Rating

MT Newswires Live
·
2 hours ago

Illumina is Maintained at Buy by Guggenheim

Dow Jones
·
Oct 01

Illumina price target raised to $305 from $226 at Guggenheim

TIPRANKS
·
Oct 01

Guggenheim Adjusts Price Target on Illumina to $305 From $226, Keeps Buy Rating

MT Newswires Live
·
Oct 01

Illumina is Maintained at Outperform by Leerink Partners

Dow Jones
·
Sep 30

Leerink Partners Sticks to Their Buy Rating for Illumina (ILMN)

TIPRANKS
·
Sep 29

Illumina price target raised to $300 from $220 at Leerink

TIPRANKS
·
Sep 29

Leerink Partners Adjusts Price Target on Illumina to $300 From $220, Keeps Outperform Rating

MT Newswires Live
·
Sep 29

Illumina Price Target Raised to $305.00/Share from $225.00 by Piper Sandler

Dow Jones
·
Sep 29

Illumina price target raised to $305 from $225 at Piper Sandler

TIPRANKS
·
Sep 28

Piper Sandler Adjusts Price Target on Illumina to $305 From $225, Keeps Overweight Rating

MT Newswires Live
·
Sep 28

Bernstein Keeps Their Hold Rating on Illumina (ILMN)

TIPRANKS
·
Sep 26

Illumina Inc Stock (ILMN) Moved Up by 7.45% on Sep 24: A Full Analysis

TradingKey
·
Sep 25

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 25

Movement Alert|Illumina Rises 5.03% in Regular Trading, Passive Fund Inflows Continue Post S&P 500 Inclusion Combined With UBS Upgrade

Market Focus
·
Sep 24

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 21

Movement Alert|Illumina Rises 5.15% in Regular Trading, Boosted by UBS Upgrade and Imminent S&P 500 Inclusion

Market Focus
·
Sep 17

Robigo and Leaps by Bayer Announce Series a Financing to Advance Engineered Biologicals

Reuters
·
Sep 17

Robigo: Funding with Participation from Illumina Ventures, Svg Thrive, Congruent Ventures, and Endeavor8

THOMSON REUTERS
·
Sep 17

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16